Cerenome, Inc. (CNSY)
2.30
-0.02
(-1.08%)
USD |
NASDAQ |
Sep 14, 10:35
Cerenome Debt to Equity Ratio : 0.0081 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0081 |
| March 31, 2026 | 0.0606 |
| December 31, 2025 | 0.2055 |
| September 30, 2025 | 0.0042 |
| June 30, 2025 | 0.0099 |
| March 31, 2025 | -0.0017 |
| December 31, 2024 | -0.3762 |
| September 30, 2024 | -0.6571 |
| June 30, 2024 | -0.4504 |
| March 31, 2024 | -0.7782 |
| December 31, 2023 | -3.102 |
| September 30, 2023 | 1.748 |
| June 30, 2023 | 1.861 |
| March 31, 2023 | 1.992 |
| December 31, 2022 | 0.8759 |
| September 30, 2022 | 0.5257 |
| June 30, 2022 | 0.6543 |
| March 31, 2022 | 0.4556 |
| December 31, 2021 | 0.6453 |
| September 30, 2021 | 0.4989 |
| June 30, 2021 | 0.609 |
| March 31, 2021 | 0.7469 |
| December 31, 2020 | 2.308 |
| September 30, 2020 | 2.634 |
| June 30, 2020 | 2.047 |
| Date | Value |
|---|---|
| March 31, 2020 | 140.49 |
| December 31, 2019 | 10.22 |
| September 30, 2019 | 73.61 |
| June 30, 2019 | -1.867 |
| March 31, 2019 | 4.301 |
| December 31, 2018 | 2.718 |
| September 30, 2018 | 2.282 |
| June 30, 2018 | 2.912 |
| March 31, 2018 | 1.619 |
| December 31, 2017 | 1.048 |
| September 30, 2017 | 1.726 |
| June 30, 2017 | 1.292 |
| March 31, 2017 | 2.185 |
| December 31, 2016 | 1.605 |
| September 30, 2016 | 1.273 |
| June 30, 2016 | 0.9165 |
| March 31, 2016 | 2.186 |
| December 31, 2015 | 1.367 |
| September 30, 2015 | 3.285 |
| June 30, 2015 | 7.173 |
| March 31, 2015 | -1.107 |
| December 31, 2014 | -4.455 |
| September 30, 2014 | -7.838 |
| June 30, 2014 | 22.50 |
| March 31, 2014 | 11.06 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ernexa Therapeutics, Inc. | 0.1091 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 14.03M |
| Total Liabilities (Quarterly) | 8.567M |
| Shareholders Equity (Quarterly) | 5.463M |
| Current Ratio | 1.346 |
| Net Debt Paydown Yield | 0.00% |